BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19334052)

  • 1. An update on the genotoxicity and carcinogenicity of marketed pharmaceuticals with reference to in silico predictivity.
    Snyder RD
    Environ Mol Mutagen; 2009 Jul; 50(6):435-50. PubMed ID: 19334052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotoxicity and carcinogenicity studies of antihypertensive agents.
    Brambilla G; Martelli A
    Mutat Res; 2006 Mar; 612(2):115-49. PubMed ID: 16458045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the sensitivity of the computational programs DEREK, TOPKAT, and MCASE in the prediction of the genotoxicity of pharmaceutical molecules.
    Snyder RD; Pearl GS; Mandakas G; Choy WN; Goodsaid F; Rosenblum IY
    Environ Mol Mutagen; 2004; 43(3):143-58. PubMed ID: 15065202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the genotoxicity of marketed pharmaceuticals.
    Snyder RD; Green JW
    Mutat Res; 2001 May; 488(2):151-69. PubMed ID: 11344042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotoxic and carcinogenic effects of antipsychotics and antidepressants.
    Brambilla G; Mattioli F; Martelli A
    Toxicology; 2009 Jul; 261(3):77-88. PubMed ID: 19410629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA intercalative potential of marketed drugs testing positive in in vitro cytogenetics assays.
    Snyder RD; Ewing D; Hendry LB
    Mutat Res; 2006 Oct; 609(1):47-59. PubMed ID: 16857419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotoxicity and carcinogenicity testing of pharmaceuticals: correlations between induction of DNA lesions and carcinogenic activity.
    Brambilla G; Mattioli F; Robbiano L; Martelli A
    Mutat Res; 2010; 705(1):20-39. PubMed ID: 20206292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotoxic and carcinogenic effects of gastrointestinal drugs.
    Brambilla G; Mattioli F; Martelli A
    Mutagenesis; 2010 Jul; 25(4):315-26. PubMed ID: 20478972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of rodent carcinogenicity utilizing a battery of in vitro and in vivo genotoxicity tests.
    Kim BS; Margolin BH
    Environ Mol Mutagen; 1999; 34(4):297-304. PubMed ID: 10618179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotoxicity and carcinogenicity studies of antihistamines.
    Brambilla G; Mattioli F; Robbiano L; Martelli A
    Arch Toxicol; 2011 Oct; 85(10):1173-87. PubMed ID: 21327970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotoxicity and carcinogenicity studies of bronchodilators and antiasthma drugs.
    Brambilla G; Mattioli F; Robbiano L; Martelli A
    Basic Clin Pharmacol Toxicol; 2013 May; 112(5):302-13. PubMed ID: 23374861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals.
    Brambilla G; Martelli A
    Mutat Res; 2009; 681(2-3):209-229. PubMed ID: 18845271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the genotoxicity of the antitussive drug Dextromethorphan.
    Aardema MJ; Robison SH; Gatehouse D; Johnston G
    Regul Toxicol Pharmacol; 2008 Apr; 50(3):285-93. PubMed ID: 18160193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on genotoxicity and carcinogenicity of antibacterial, antiviral, antimalarial and antifungal drugs.
    Brambilla G; Mattioli F; Robbiano L; Martelli A
    Mutagenesis; 2012 Jul; 27(4):387-413. PubMed ID: 22228823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of 75 marketed pharmaceuticals using the GADD45a-GFP 'GreenScreen HC' genotoxicity assay.
    Hastwell PW; Webster TW; Tate M; Billinton N; Lynch AM; Harvey JS; Rees RW; Walmsley RM
    Mutagenesis; 2009 Sep; 24(5):455-63. PubMed ID: 19592503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotoxicity and carcinogenicity studies of benzodiazepines.
    Brambilla G; Carrozzino R; Martelli A
    Pharmacol Res; 2007 Dec; 56(6):443-58. PubMed ID: 17920927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods.
    Matthews EJ; Kruhlak NL; Cimino MC; Benz RD; Contrera JF
    Regul Toxicol Pharmacol; 2006 Mar; 44(2):97-110. PubMed ID: 16352383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotoxicity and carcinogenicity studies of analgesics, anti-inflammatory drugs and antipyretics.
    Brambilla G; Martelli A
    Pharmacol Res; 2009 Jul; 60(1):1-17. PubMed ID: 19427580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.